Ajanta Pharma Ltd.
Ajanta Pharma Ltd. appears in FDA public data with 3 recalls, 0 510(k) clearances, 6 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0515-2026, Class II) was initiated on April 29, 2026.
Summary
- Total Recalls
- 3
- 510(k) Clearances
- 0
- Inspections
- 6
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0515-2026 | Class II | Duloxetine Delayed-Release Capsules, 60 mg, Rx Only, 30 capsules, Marketed by: Ajanta Pharma USA Inc | April 29, 2026 |
| D-0514-2026 | Class II | Duloxetine Delayed-Release Capsules, 30 mg, Rx Only, a) 90 Capsules, NDC 27241-098-09, b) 30 capsule | April 29, 2026 |
| D-0516-2026 | Class II | Duloxetine Delayed-Release Capsules, 20 mg, Rx Only, 60 capsules, Marketed by: Ajanta Pharma USA Inc | April 29, 2026 |